Previously, a few studies showed increased platelet counts and coagulation factors[23,24] as well as increased plasminogen activator inhibitor-1 and decreased thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism,[25] suggesting that hypercalcemia induces hemostatic imbalance. This evidence concerns the gene CPB2 and hypercalcemia disease.